Free provider profile
IVAN CICHOWICZ, M.D.
Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2017-02-03.
2201 NW CORPORATE BLVD SUITE 202, BOCA RATON, FL, 33431
561-499-6932
Single practice location
Enumerated 2007-05-07
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 9 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
4,986
Medicare patients
389
Part D drug cost
$894,764
Brand-name share
7.8%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Nuplazid (Pimavanserin Tartrate) | 21 | $153,090 |
| Austedo (Deutetrabenazine) | 16 | $112,105 |
| Ingrezza (Valbenazine Tosylate) | 12 | $102,089 |
| Trintellix (Vortioxetine Hydrobromide) | 101 | $83,433 |
| Rexulti (Brexpiprazole) | 38 | $70,983 |
| Caplyta (Lumateperone Tosylate) | 41 | $65,217 |
| Lybalvi (Olanzapine/Samidorphan Malate) | 13 | $19,545 |
| Vraylar (Cariprazine Hcl) | 11 | $17,115 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
2024399 sessions · 28 patients · $349,366
2023195 sessions · 20 patients · $176,287
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.